Evaluation of and Treatment for Monosymptomatic Enuresis: A Standardization Document From the International Children's Continence Society

Purpose

We provide updated, clinically useful recommendations for treating children with monosymptomatic nocturnal enuresis.

Materials and Methods

Evidence was gathered from the literature and experience was gathered from the authors with priority given to evidence when present. The draft document was circulated among all members of the International Children's Continence Society as well as other relevant expert associations before completion.

Results

Available evidence suggests that children with monosymptomatic nocturnal enuresis could primarily be treated by a primary care physician or an adequately educated nurse. The mainstays of primary evaluation are a proper history and a voiding chart. The mainstays of primary therapy are bladder advice, the enuresis alarm and/or desmopressin. Therapy resistant cases should be handled by a specialist doctor. Among the recommended second line therapies are anticholinergics and in select cases imipramine.

Conclusions

Enuresis in a child older than 5 years is not a trivial condition, and needs proper evaluation and treatment. This requires time but usually does not demand costly or invasive procedures.

Key Words: urinary bladder, nocturnal enuresis, reference standards, societies, medical, child

Abbreviations and Acronyms: ICCS, International Children's Continence Society, MNE, monosymptomatic NE, NE, nocturnal enuresis, NMNE, nonmonosymptomatic NE, UTI, urinary tract infection